Viewing Study NCT00003658


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-01-03 @ 3:09 PM
Study NCT ID: NCT00003658
Status: COMPLETED
Last Update Posted: 2013-06-25
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Waldenström macroglobulinemia View
None stage II chronic lymphocytic leukemia View
None stage III chronic lymphocytic leukemia View
None stage IV chronic lymphocytic leukemia View
None refractory chronic lymphocytic leukemia View
None B-cell chronic lymphocytic leukemia View
None stage I grade 1 follicular lymphoma View
None stage I grade 2 follicular lymphoma View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None contiguous stage II grade 1 follicular lymphoma View
None contiguous stage II grade 2 follicular lymphoma View
None noncontiguous stage II grade 1 follicular lymphoma View
None noncontiguous stage II grade 2 follicular lymphoma View
None contiguous stage II small lymphocytic lymphoma View
None noncontiguous stage II small lymphocytic lymphoma View
None recurrent small lymphocytic lymphoma View
None stage I small lymphocytic lymphoma View
None stage III small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View